XTX Topco Ltd increased its holdings in Tilray Inc (NASDAQ:TLRY – Free Report) by 1,079.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 281,504 shares of the company’s stock after acquiring an additional 257,641 shares during the quarter. XTX Topco Ltd’s holdings in Tilray were worth $495,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of TLRY. Ferguson Wellman Capital Management Inc. purchased a new stake in shares of Tilray in the third quarter worth $26,000. Signature Estate & Investment Advisors LLC purchased a new stake in Tilray during the 2nd quarter valued at about $29,000. Jeppson Wealth Management LLC bought a new stake in Tilray during the 2nd quarter valued at about $33,000. Pallas Capital Advisors LLC purchased a new position in Tilray in the second quarter worth about $37,000. Finally, Vanguard Capital Wealth Advisors bought a new position in shares of Tilray in the second quarter worth approximately $34,000. Institutional investors own 9.35% of the company’s stock.
Insiders Place Their Bets
In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the firm’s stock in a transaction on Friday, November 15th. The shares were acquired at an average cost of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the transaction, the chief financial officer now owns 26,000 shares of the company’s stock, valued at approximately $35,360. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.87% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on TLRY
Tilray Stock Performance
Shares of NASDAQ TLRY opened at $1.19 on Friday. The firm’s 50-day moving average price is $1.48 and its 200-day moving average price is $1.67. Tilray Inc has a 52-week low of $1.15 and a 52-week high of $2.97. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting analysts’ consensus estimates of ($0.04). The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm’s revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.10) EPS. As a group, equities analysts predict that Tilray Inc will post -0.14 earnings per share for the current year.
Tilray Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
- Five stocks we like better than Tilray
- Comparing and Trading High PE Ratio Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a support level?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.